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ABSTRACT
Calcium phosphate nanoparticles have shown potential as non-viral vectors for gene delivery. The aim
of this study was to induce bone morphogenetic protein (Bmp)2 transfection in rat dental pulp stem cells
using calcium phosphate nanoparticles as a gene vector and then to evaluate the efficiency and bioactivity
of the transfection. We also intended to investigate the behavior of transfected cells when seeded on 3-
dimensional titanium fiber mesh scaffolds. Nanoparticles of calcium phosphate encapsulating plasmid
deoxyribonucleic acid (DNA) (plasmid enhanced green fluorescent protein-BMP2) were prepared. Then,
STRO-1-selected rat dental pulp stem cells were transfected using these nanoparticles. Transfection and
bioactivity of the secreted BMP2 were examined. Thereafter, the transfected cells were cultured on a fi-
brous titaniummesh. The cultures were investigated using scanning electron microscipy and evaluated for
cell proliferation, alkaline phosphatase activity and calcium content. Finally, real-time polymerase chain
reaction was performed for odontogenesis-related gene expression. The results showed that the size of the
DNA-loaded particles was approximately 100 nm in diameter. Nanoparticles could protect the DNA en-
capsulated inside from external DNase and release the loaded DNA in a low-acid environment (pH 3.0).
In vitro, nanoparticle transfection was shown to be effective and to accelerate or promote the odontogenic
differentiation of rat dental pulp stem cells when cultured in the 3-dimensional scaffolds. Based on our
results, plasmid DNA–loaded calcium phosphate nanoparticles appear to be an effective non-viral vector
for gene delivery and functioned well for odontogenic differentiation through Bmp2 transfection.
INTRODUCTION
IN TISSUE ENGINEERING, GENE THERAPY is used as a means ofdelivering genes locally to somatic cells, encoding for
proteins like growth factors, transcription factors, or extra-
cellular matrix molecules with a resulting therapeutic effect.
The applied genes can stimulate or induce a natural bio-
logical process by expressing bioactive molecules that are
involved in the regenerative response of the tissue.1 Gene
therapy can be a valuable tool to avoid the limitations of
local delivery of growth factors, including short half-life,
large dose requirement, high cost, need for repeated appli-
cations, and poor distribution.2 In our previous study, an
adenoviral-mediated human bone morphogenetic protein
(Bmp)2 gene was transfected into STRO-1-selected rat den-
tal pulp stem cells (DPSCs) and showed its ability to pro-
mote odontogenic action effectively.3 However, the clinical
application of an adenovirus is not advisable, because it
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results in endogenous recombination, oncogenic effects, and
toxic immunological reactions, leading to potential serious
complications.4,5 For this reason, use of a number of non-
viral vectors have been explored. The application of inor-
ganic nanoparticles with entrapped deoxyribonucleic acid
(DNA) is a new field for non-viral transfection and is ex-
pected to overcome the limitations mentioned above. The
advantages of these vectors are the ease of manufacture, low
cost, stability, low immunogenicity, and low risk for the
plasmid to be inserted into the host cell genome. In the lit-
erature, plasmid DNA (pDNA)-loaded calcium phosphate
nanoparticles have already been demonstrated to be highly
efficient for transfection in the Hela cell line.6,7
The osteoinductive potential of recombinant human BMP2
(hBMP2) has already been confirmed in a clinical study.8 In
our study, the recombinant human BMP2 gene was used for
transfection because it can stimulate the differentiation of
adult dental pulp cells into odontoblasts, and it also plays a
role during the various stages of the formation of hard skel-
etal and dental tissue in bone and teeth.9–11 Furthermore, for
our dental tissue–engineering purposes, DPSCs were used as
these responding stem cells in nature. A hierarchy of DPSCs
causes the variable behavior of these cells in vitro and results
in a low therapeutic potential in vivo.12,13 STRO-1þ DPSCs
were chosen because selection with this marker increased the
ability of osteo- and odontogenic differentiation, as well as
development toward other differentiation pathways.3,14,15
In this study, we intended to transfect STRO-1-selected
rat DPSCs with pDNA entrapped in calcium phosphate na-
noparticles. We hypothesized that calcium phosphate na-
noparticles would result in a relatively high transfection
efficacy and that the secreted BMP2 would be effective in
odontoinductive action.
MATERIAL AND METHODS
Preparation of pDNA-loaded calcium
phosphate nanoparticles
A recombinant green fluorescent eukaryotic cell expres-
sing the plasmid-carrying hBmp2 gene (plasmid enhanced
green fluorescent protein-BMP2 (pEGFP-BMP2), was used
in the current study. The preparation of pDNA-loaded cal-
cium phosphate nanoparticles followed the protocol of Bisht
et al.7 The basic method was as follows; 0.1 M bis (2-
ethylhexyl) sulphosuccinate (Aerosol-OT, AOT), solution
in hexane (Sigma, St. Louis, MO) was prepared. In 25 mL
of AOT in hexane, 70-mL of aqueous solution of 1.36 M
calcium chloride and aqueous solution of 2.94 mg of pDNA
were added by continuous stirring overnight to form a micro-
emulsion ‘‘A.’’ In another 25 mL of AOT solution, 50 mL
of 0.2 M Tris–hydrochloric acid buffer (pH 7.4), 70 mL of
aqueous solution of 0.35 M dibasic sodium phosphate, and
an aqueous solution of 2.94 mg of pDNA were dissolved by
continuous stirring overnight to form micro-emulsion ‘‘B.’’
Before stirring both micro-emulsions, excess water was
added to make the total volume of 450 mL to adjust the molar
ratio of water to AOT at 10 to 1. Then, micro-emulsion ‘‘B’’
was added to ‘‘A’’ at an extremely slow rate (5 mL per min)
with continuous stirring at 48C and was kept in the same
condition overnight. Subsequently, hexane was carefully re-
moved from the resulting solution after centrifuging 30 min
at 5000 revolutions per min at 48C. The sediment was dis-
solved in 10 mL of absolute ethanol by vortexing, followed
again by centrifugation. After 3 such cycles, the pelleted
nanoparticles were dispersed in Milli-Q water at 48C by
vortexing. Finally, the dispersed nanoparticles were lyophi-
lized to dry powder (yield *1 mg).
Morphology and characteristics of the nanoparticles
Transmission electron microscopy. To evaluate the size of
the nanoparticles, 1 drop of aqueous dispersion of the par-
ticles was put on a Forvmar-coated copper grid and air dried
at room temperature. The dried grid was examined under a
JEOL (Tokyo, Japan) 1101 transmission electron micro-
scope (TEM) coupled to digital image analysis software.
Approximately 25 particles were measured.
Gel electrophoresis. To check the protection of DNA in
the nanoparticles from external DNase degradation, 20 mL of
aqueous dispersion of calcium phosphate/DNA nanopar-
ticles (containing 1 mg of pDNA) prepared by the above
method was incubated with 5 mL of DNaseI (5 mg/mL) at
378C for different time intervals (0, 0.5, and 1 h) and then
loaded in 1% agarose gel. As positive and negative controls,
10 mL of free pDNA was loaded alone or after incubation
with DNaseI.
Entrapment efficiency. The entrapment efficiency of
DNA attached to the nanoparticles was evaluated by dis-
solving the particles in acidic buffer (pH 3.0) and incubating
overnight. The amount of pDNA released from the nano-
particles ([pDNA]r) was estimated spectrophotometrically
by measuring the optical density (OD) at l¼ 260 nm. The
entrapment efficiency was then calculated from the amount
of DNA originally added in the solution ([pDNA]0), using
the equation E%¼ [pDNA]r/[pDNA]0100.
In vitro transfection studies
Cell culture. Rat DPSCs (10th passage) were selected on
the stem cell marker STRO-1 using fluorescence-activated
cell sorting, as described previously,17 and expanded in min-
imal essential medium-alpha (a-MEM; GIBCO-BRL, Breda,
The Netherlands) supplemented with 10% fetal calf serum
(FCS; GIBCO-BRL) and 50mg/mL of gentamycin (Sigma).
Determination of transfection efficiency. The cells were
seeded in 24-well plates at a density of 2104 cells in 1 mL
of culture medium per well. Upon reaching 80% confluency,
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cells were used for transfection. Then 0.3 mL of pEGFP-
BMP2-loaded calcium phosphate nanoparticles in a-MEM
without FCS and antibiotics (total amount of pDNA
*0.5 mg) was added to each well. After incubation at 378C
for 4 h, the transfection complex was replaced with fresh a-
MEM containing 10% FCS and antibiotics. Exactly 48 h
post-transfection, cells were detached to detect green
fluorescence using fluorescence microscopy to confirm tem-
porary transfection. Simultaneously, the supernatants were
collected on days 2, 4, 6, 8, and 10 after transfection.
Aliquots of 50 mL of these samples were used to measure
the concentration of recombinant hBMP2 by using a BMP2
enzyme-linked immunosorbent assay (ELISA) kit (Quan-
tikine, R&D Systems, Inc. Minneapolis, MN) (n¼ 6). Also,
at days 1, 4, 8, and 16 after transfection, the proliferation
rates of the cells, as measured according to total DNA con-
tent (n¼ 6), were assessed using a Pico Green double-strand
DNA quantification kit (Molecular Probes, Leiden, The
Netherlands).16 The commercial transfection reagent Lipo-
fectamine 2000 (Invitrogen, Gaithersburg, MD) was used as
a control using the same cell density and incubation times.
The bioactivity of hBMP2 produced from transfected
cells was assessed according to alkaline phosphatase (ALP)
activity upregulation using the cell line W20-17, as reported
previously.20 Briefly, 48 h post-transfection, the superna-
tants were collected and filtered. Then these conditioned
media were transferred to 80% confluent W20-17 cells
(n¼ 6). After an additional 48 h of incubation, a lysate was
prepared to measure ALP activity of the W20-17 cells.17
Three-dimensional scaffold culture
Titanium fiber mesh (Bekenit, SaitamaKen, Japan) was
used as a 3-dimensional (3-D) scaffold. The fiber diameter
was 45mm.Thevolumetric porosityof the totalmeshwas86%,
and the weight was 400 g/m2. A titanium fiber mesh sheet
was cut into discs of 6 mm in diameter and 1 mm in thickness,
and then scaffolds were sterilized using autoclaving.
Cell seeding. All scaffolds were pre-wetted in a-MEM
with 10% FCS and 50 mg/mL of gentamycin overnight.
Forty-eight h post-transfection, STRO-1-selected DPSCs
were seeded onto the scaffolds by incubating the scaffolds
in a suspension of 1.0106 cells/mL while gently rotating at
6 revolutions per min for 3 h. For every 6 scaffolds, 1 mL of
cell suspension was used. Subsequently, the scaffolds were
put in 24-well plates for culturing with a-MEM supple-
mented with 10% FCS, 10 mM sodium b-glycerophosphate,
108 M dexamethasone, 50 mg/mL of L-ascorbic acid, and
50 mg/mL of gentamycin. The non-transfected cells were
used as a control and cultured in the same osteogenic me-
dium as above or in non-osteogenic medium (a-MEM sup-
plemented with 10% FCS and 50 mg/mL of gentamycin.).
Culture media were replaced at 3-day intervals.
Cell proliferation, ALP activity, and calcium content. On
days 1, 4, 8, 16, and 24 post-seeding, the proliferation rates
of cells, as measured according to total DNA content (n¼ 3),
were assessed. The same samples as used above were also
used to measure ALP activity. Twenty mL of 0.5 AMP buffer
(Sigma) was added to 80 mL of the samples or standards.
Next, 100 mL of substrate solution was added, and the mix-
tures were incubated at 378C for 1 h. ALP activity was mea-
sured at 405 nm using an ELISA microplate reader (Bio-Tek
Instruments Inc., Winooski, VT). On days 4, 8, 16, and 24
after seeding, the calcium content of the samples (n¼ 3) was
measured using the o-cresolphthalein complexone (Sigma)
method.16
Scanning electron microscopy. On days 1, 8, and 24 after
cell seeding, scaffolds were rinsed with filtered PBS, fixed
in 2% glutaraldehyde for 5 min, dehydrated in graded series
of ethanol, and dried in tetramethylsilane (Merck, Darm-
stadt, Germany). Gold was sputtered on the samples just
before SEM analysis. The specimens were examined using
a JEOL 6310 SEM at an accelerating voltage of 10 kV.
Real-time quantitative polymerase chain reaction. In a
pilot study preceding the current experiment (data not
shown), we found that the messenger ribonucleic acids
(mRNAs) were active and detectable for 16 days and sub-
sequently significantly descended to day 24, so for the cur-
rent study only, at days 1, 4, 8, and 16 after cell seeding,
total RNA of every sample was prepared with Qiagen
RNEasy kit (Qiagen, Venlo, The Netherlands). Then, 1 mg of
total RNA was used to perform the reverse transcriptase
(RT) reaction. The obtained complementary DNA was used
as a template in PCR. The odontogenic differentiation of cells
was monitored according to specific markers: ALP, collagen
type I (Col I ), osteocalcin (OC), dentin sialophosphoprotein
TABLE 1. THE RAT-SPECIFIC PRIMER SEQUENCES USED FOR REAL-TIME POLYMERASE CHAIN REACTION
Sense primer Antisense primer
ALP 50-GCTTCACGGCATCCATGAG- 30 50-GAGGCATACGCCATGACGT-3
OC 50-GGCTTCCAGGACGCCTACA-3 50-CATGCCCTAAACGGTGGTG-30
Col I 50-TGGAATCTTGGATGGTTTGGA-30 50-GCTGTAAACGTGGAAGCAAGG-30
DSPP 50-CGGTCCCTCAGTTAGTC-30 50-TACGTCCTCGCGTTCT-30
DMP-1 50-CGTTCCTCTGGGGGCTGTCC-30 50-CCGGGATCATCGCTCTGCATC-30
GAPDH 50-GAAGGGCTCATGACCACAGT-30 50-GGATGCAGGGATGATGTTCT-3
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(DSPP), and dentin matrix protein 1 (DMP-1). Glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) was used as a
housekeeping gene to normalize RNA expression (Table 1).
Real-time PCR was performed using SYBR Green PCR
kit (Eurogentec, Liege, Belgium) and controlled in a spec-
trofluorometric thermal iCycler (Bio-Rad, Veenendaal, The
Netherlands). After the real-time PCR run, the threshold
cycle (Ct) value showed how many PCR cycles were nec-
essary to obtain a certain level of fluorescence. Amplification
efficiency of different genes was determined relative to
GAPDH as an internal control (DCt¼Ct geneCt GAPDH).
The mRNA in each sample was calculated using the com-
parative DDCt (DCt geneDCt control) value method. Each
sample was assessed in triplicate.
Statistical analysis
Statistical significance was evaluated using one-way
analysis of variance with post hoc Tukey testing. As indi-
cated, p< 0.05 was considered significant. Error bars rep-
resent means  standard deviations.
RESULTS
pDNA-loaded calcium phosphate nanoparticles
After continuous stirring overnight, the micro-emulsions
‘‘A’’ and ‘‘B’’ showed optically clear solutions. In the re-
sulting solution (mixture of ‘‘A’’ and ‘‘B’’), development of
translucency implicated nanoparticle formation in the aque-
ous core of the micro-emulsion droplets. The TEM inves-
tigation revealed the formation of dense particles with a
spherical morphology. When dispersed in water, the particle
size was in the range of 75–100 nm in diameter (Fig. 1). The
resistance of pDNA-loaded calcium phosphate complexes to
external aggressive DNase attack was demonstrated using gel
electrophoresis (Fig. 2). Although free pDNA could move to
the usual position (*6 kb) and could also be completely
digested by external DNase, the plasmid-loaded complexes
had hardly moved and stayed at the top of the lanes. One mg
of pDNA-loaded nanoparticles, in which the original amount
of applied DNA was 5.88 mg, was used to evaluate the en-
trapment efficiency of DNA inside the nanoparticles. After
overnight incubation, the entrapment efficiency was calcu-
lated as 97.15% 2.04% (n¼ 4).
In vitro transfection studies
The successful transfection could be easily traced using
green fluorescence protein (GFP). Forty-eight h post-
treatment of nanoparticles, the DPSCs showed the expres-
sion of green fluorescence, visually demonstrating a similar
positive rate to that of cells transfected using Lipofectamine
2000 (Fig. 3). The amount of hBMP2 secreted by trans-
fected rat DPSCs was quantitated using ELISA (Fig. 4A).
With Lipofectamine 2000 transfection, the cells produced
significantly more hBMP2 on day 2, although on days 8 and
10, the expression of hBMP2 was significantly lower. The
DNA results showed significantly higher cell numbers in
the nanoparticle group for all time points except on day 16,
although the trend of proliferation was similar to the cells
transfected with Lipofectamine 2000 (Fig. 4B). The bio-
activity of hBMP2 was assessed according to the ability of
conditioned media to upregulate the ALP activity of the
BMP2-sensitive W20-17 cell line (Fig. 4C). The medium
from rat DPSCs transfected with nanoparticles demon-
strated significantly greater W20-17 ALP activity than in
the control group of non-transfected cells ( p< 0.01).
3-D scaffold culture
The cell proliferation rates are depicted in Figure 5A.
Analysis of the data showed that the proliferation of non-
transfected rat DPSCs in non-osteogenic medium was
significantly faster than that of transfected cells and non-
transfected rat DPSCs in osteogenic medium, although no
significant differences were found between these latter 2
groups. The ALP activity of both cell groups cultured in
osteogenic medium increased over 24 days, but transfected
DPSCs showed significantly higher levels after day 4 than
non-transfected cells (Fig. 5B). The non-transfected cells
cultured in non-osteogenic medium always demonstrated
significantly lower levels of ALP activity ( p< 0.01) and
only started to increase after day 8. The calcium content
increased significantly between days 8 and 24 for 2 cell
groups cultured in osteogenic medium ( p< 0.01), but the
transfected cells showed significantly higher levels after day
16 than non-transfected cells ( p< 0.01) (Fig. 5C).
SEM observation showed that cells already attached and
spread on the surface of Ti-fibers after 1 day of seeding
and proliferated along the culture. The rat DPSCs in non-
FIG. 1. Transmission electron micrograph of plasmid deoxy-
ribonucleic acid–encapsulated calcium phosphate nanoparticles.
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osteogenic culture grew faster than the two groups in oste-
ogenic culture and almost completely filled the Ti-mesh
voids on day 8 (Fig. 6A–C). By day 8, the 2 cultures in
osteogenic medium began to produce collagen and to form
mineralized nodules. After 24 days of incubation, more nu-
merous and larger mineralized globular accretions always
associated with collagen bundles were observed (Fig. 6D,
E). In the non-osteogenic cell culture, the formation of a min-
eralized extracellular matrix was never observed (Fig. 6F).
Expression levels of mRNA for ALP, Col I, OC, DSPP,
and DMP-1 were compared on days 1, 4, 8, and 16. mRNA
expression levels of non-osteogenic cell cultures on day 1
were set as baseline controls (relative expression value,
100%). Results showed that ALP was significantly greater in
transfected cells (Fig. 7A). Col I showed up-regulation for
all 3 groups and was significantly higher in cells cultured
in non-osteogenic medium (Fig. 7B). OC showed some up-
regulation in the 2 groups cultured in osteogenic medium at
days 8 and 16, but the expression level of transfected cells was
significantly higher than of non-transfected cells at day 8 (Fig.
7C). The expression of DSPP and DMP-1 revealed a signifi-
cantly greater number of cells cultured in osteogenic medium
at days 8 and 16, although the transfected cells had a higher
expression levels than the non-transfected cells (Fig. 7D, E).
DISCUSSION
Effective gene delivery into mammalian somatic cells
in vitro and in vivo is an essential step in gene therapy. In
this study, we have demonstrated gene transfection and a
subsequent odonto-stimulatory effect in STRO-1-selected
rat DPSCs through pEGFP-BMP2-loaded calcium phos-
phate nanoparticles.
FIG. 2. Agarose gel (1%) electrophoresis. Lane 1: Deoxyribonucleic acid (DNA) marker. Lane 2: free permuted enhanced green
fluorescent protein–bone morphogenetic protein 2 (pEGFP-BMP2) DNA (6 kb). Lane 3: pEGFP-BMP2 DNA treated with DNase for
0.5 h. Lane 4: pEGFP-BMP2-loaded calcium phosphate nanoparticles. Lane 5: pEGFP-BMP2-loaded calcium phosphate nanoparticles
treated with DNase for 0.5 h. Lane 6: pEGFP-BMP2-loaded calcium phosphate nanoparticles treated with DNase for 1 h.
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FIG. 3. Fluorescent micrographs of green fluorescent protein expression in permuted enhanced green fluorescent protein–bone
morphogenetic protein 2–transfected rat dental pulp stem cells. (A) Calcium phosphate nanoparticle group; (B) Lipofectamine group
(original magnification 10). Color images available online at www.liebertpub.com/ten.
FIG. 4. (A) Enzyme-linked immunosorbent assay for human bone morphogenetic protein 2 (hBMP2) concentration in 3 groups. The
bars represent means standard deviations (SDs) (n¼ 6). The calcium phosphate nanoparticle group (NP) compared with the Lipo-
fectamine group (Lipo): *p< 0.05, **p< 0.01; NP group compared with non-osteogenic group (control): ##p< 0.01. (B) The prolif-
eration characteristics of 2 groups. The bars represent means  SDs (n¼ 6). NP group compared with lipo group (Lipo): *p< 0.05,
**p< 0.01. (C) The bioactivity of hBMP2 produced from transfected rat dental pulp stem cells (DPSCs) mediated with nanoparticles
48 h post-transfection. Bioactivity was assessed according to up-regulation of alkaline phospotase activity in W20-17 cells induced by
conditional medium incubated with rat DPSCs. The bars represent the means SDs (n¼ 6). NP group compared with non-osteogenic
group (control): **p< 0.01. DNA, deoxyribonucleic acid.
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Two classical types of non-viral vectors are liposomal
formulations and cationic polymers. Unfortunately, it has
been observed that, in addition to cytotoxicity, these vectors
do not always lead to satisfactory efficacy of gene expression
in the cells. The reasons may be due to low endosomal es-
cape, no protection of DNA from nuclease degradation, and
inefficient nuclear uptake.18–20 Calcium ions are known to
form ionic complexes with the helical phosphates of DNA,
and these complexes have easy transportability across the
cell membrane via ion channel–mediated endocytosis.21 It
was envisaged that the use of nanoparticles of inorganic
calcium might eliminate many of these limitations. Previ-
ous studies have reported the use of pDNA encapsulated in
calcium phosphate nanoparticles as gene carriers. These
calcium phosphate nanoparticles have a well-defined role in
DNA delivery as far as endosomal escape, protection against
nuclease degradation, and nuclear uptake are concerned.6,7
The literature shows that 5.88 mg of pDNA per mg of
calcium phosphate can be loaded in the nanoparticles.6
Using the same ratio, we also acquired particles less than
100 nm in diameter. It has been confirmed that particles
greater than 200 nm in diameter are not efficiently taken up
by endocytosis and thus only via phagocytosis. 22 One pre-
vious study showed that the surface charge of DNA-loaded
calcium phosphate nanoparticles is positive in neutral aque-
ous buffer,6 resulting in non-movable nanoparticles in nor-
mal electrophoresis running toward the anode. Furthermore,
the DNA encapsulated in calcium phosphate particles was
protected for the external DNase environment, which was
favorable for the survival of DNA after endocytosis.
The endosomal escape and the nuclear uptake are the fi-
nal obstacles for DNA delivery.20 It has been demonstrated
that calcium ions play an important role in endosomal es-
cape, cytosolic stability, and enhanced nuclear uptake of
DNA through nuclear pore complexes.23 The inorganic na-
noparticles are necessary as DNA carriers for entry into
the cell. In our case, the DNA-doped nanoparticles are
FIG. 5. (A) The proliferation characteristics; (B) alkaline phos-
phatase (ALP) activity; (C) calcium content. The bars represent
the means standard deviations (n¼ 3). The calcium phosphate
nanoparticle group (NP) compared with the group in osteogenic
medium (Oþ) *p< 0.05, **p< 0.01; NP group compared with the
group in non-osteogenic medium (O-): #p< 0.05, ##p< 0.01.
FIG. 6. Scanning electron micrographs of 3 cell populations on
day 8: (A) the transfected dental pulp stem cells (DPSCs), (B) the
DPSCs in osteogenic medium, (C) the DPSCs in non-osteogenic
medium, On day 24: (D) the transfected DPSCs, (E) the DPSCs in
osteogenic medium, (F) the DPSCs in non-osteogenic medium.
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FIG. 7. Representative curves of the messenger ribonucleic acid levels of alkaline phosphatase (A); collagen type I (B); osteocalcin (C);
dentin sialophosphoprotein (D); dentin matrix protein 1 (E) quantified during 16 days. The bars represent means standard deviations
(n¼ 3). The calcium phosphate nanoparticle group (NP) compared with the group in osteogenic medium (Oþ) *p< 0.05, **p< 0.01; NP
group compared with the group in non-osteogenic medium (O-): #p< 0.05, ##p< 0.01.
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non-crystalline, in contrast to voided calcium phosphate
nanoparticles.6,7 In the present study, we observed success-
ful gene expression from nanoparticle-mediated cells, and
the gene products were bioactive. As a control, Lipofecta-
mine-mediated cells were used, which were shown to pro-
duced higher hBMP2 levels initially, although at later time
points, the nanoparticle-mediated group reached higher
levels. The final amount of BMP seems to be the most in-
teresting output parameter when subsequently going to
validation (animal) studies. Differences can be the result of
different methods of endosomal escape. After endocytosis,
lipid–DNA compounds internalize into the endosome
and initiate the destabilization of the endosomal membrane
for escaping.20,24 However, the dissolution of inorganic
nanoparticles in the acidic endosomal compartment (pH 5.0–
5.5) results in an osmotic imbalance and the consequent
disruption of the endosome so that DNA can escape into
the cytosol.6 There were fewer cells transfected with Lipo-
fectamine from day 1 to 8 than in the nanoparticle group,
which might have been because of the cytotoxicity of
cationic liposomes.25 Altogether, Lipofectamine was ad-
vantageous for the BMP level obtained at the beginning
(i.e., at day 2), but after that, the nanoparticle strategy was
superior.
Titanium fiber mesh is a highly biocompatible material,
and its non-degradable nature is not necessarily disadvan-
tageous for hard-tissue applications. Previous studies have
demonstrated that titanium fiber mesh, which has been
used for bone regeneration,26 supportss the attachment,
growth, and differentiation of dental pulp cells in vivo and
in vitro.16,27 In the current study, the non-osteogenic DPSC
culture proliferated faster because of the inverse relationship
between proliferation and differentiation (i.e., when cells are
more proliferative then the slowing in differentiation of the
cells and vice versa).28 It is known that BMP2 in high con-
centrations can stimulate the early differentiation of cells
and the formation of extracellular matrix while not influ-
encing proliferation.29
ALP is a prerequisite for the differentiation of dental pulp
cells. We observed a longer period of ALP activity than in
previous studies.16 A 3-D scaffold provides a larger surface
area for cell attachment than a smooth substrate, which is
favorable for the spreading and interaction of cells and thus
results in a longer increase in the ALP activity.16 Moreover,
in our study, STRO-1-selected rat DPSCs were used, which
showed earlier up-regulation of ALP activity than did non-
selected rat dental pulp cells on a similar scaffold16 because
of the more homogeneous cells from STRO-1 selection.15
Comparison of ALP activity between the 2 groups that were
cultured in the osteogenic medium revealed that the secreted
BMP2 from the nanoparticle-transfected cells exerts its ef-
fect and accelerates the odontogenic differentiation and
matrix mineralization of DPSCs. Previous studies have re-
vealed that BMP2 functions in a dose-dependent manner.
High concentrations (e.g., 100 ng/mL) of BMP2 demon-
strated the induction of an osteoblastic phenotype.29,30 Our
study shows that the transfected cells mediated with nano-
particles produce less than 100 ng/mL of hBMP2, although
the transfected cells can continuously secrete the Bmp2 gene
product into the medium, which may account for similar
bio-functionality to the higher concentrations necessary with
BMP2 as a protein supplement in a single application.31
Furthermore, calcium content measurement demonstrated
that the transfected cells led to more mineralization, and
SEM observation showed that mineralized matrix fully
covered many cells. Although a previous study showed
that calcium phosphate nanocomposites by themselves can
induce cell differentiation and bone formation,32 we feel that
the gene products were mostly responsible for cell differ-
entiation, especially bearing in mind the low-dose calcium
phosphate particles used in this study. Ideally, an empty
nanoparticle would have been used as negative control, but
this was not possible, because the production of non-DNA-
loaded particles would have resulted in different properties
regarding morphology, composition, and crystallinity.
The real-time PCR further confirmed the results men-
tioned above. It is known that mRNA expression is always
seen before protein expression. mRNA expression of ALP
also continued to increase and reached a peak at day 16
for cells in osteogenic culture, whereas the transfected
cells had a more-sensitive reaction. Collagen type I is the
predominant collagen in dentin and bone matrix and
the foundation of the extracellular matrix on which fu-
ture mineralization takes place. Higher levels of collagen
type I mRNA were found in cells from non-osteogenic
culture, which was in concordance with the cell growth
profiles found through DNA analysis and SEM. OC, a non-
collagenous protein, is also present in dentin and bone
matrix. mRNA expression of OC showed similar profiles to
those found in a previous study.16 However, the two groups
in osteogenic culture demonstrated differences only at
day 8. This may be due to the BMP2, which stimulates the
early differentiation of cells, whereas OC is known as a
late-phase marker for terminal cell differentiation and
matrix mineralization.33 DSPP is the major part of non-
collagenous proteins in natural dentin and plays a crucial
role during dentin mineralization.34 DMP-1 is another
specific protein in dentin and is a candidate gene for den-
tinogenesis imperfecta.35 Expression of these mRNAs can
prove that these cells exhibit an odontoblast phenotype.
CONCLUSIONS
Based on our results, we concluded that rat STRO-1-
selected DPSCs can be successfully transfected with
pEGFP-BMP2-loaded calcium phosphate nanoparticles. In
some aspects, this nanoparticle vector was superior to
the commercial Lipofectamine transfection reagent. The
secreted BMP2 reached a functional level and accelerated
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odontogenic differentiation. Consequently, calcium phos-
phate nanoparticles can be considered a valid candidate as a
non-viral gene vector. Meanwhile, the established combi-
nation of a more-homogeneous cell population with gene
transfection can be a strategy to improve the efficacy of
DPSCs for hard-tissue engineering.
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